Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 554 insiders at 344 companies
- $9.7B sold by 666 insiders outside a trading plan
- $4.6B sold by 965 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Sean Searby EVP Chief Info. & Ops. OfficerAMALAmalgamated Financial Corp.Planned sale$158K 3,314 shares at $47.75 16% of stakeTraded Sep 15 Filed Sep 17
-
Jennifer Newstead SVP, GC and Government AffairsAAPLApple Inc ComPlanned sale$475K 1,438 shares at $330.19 4.2% of stakeTraded Sep 15 Filed Sep 17
-
Fiorenzo Villani See RemarksALPAlpha Compute CorpBuy$109K 26,547 shares at $4.11Traded Sep 14–16 Filed Sep 17
-
Ashley F. Johnson CFOPLPlanet Labs PBCPlanned sale$944K 55,663 shares at $16.96 8.8% of stakeTraded Sep 17 Filed Sep 17
-
Rong Zhou Senior EVP, Production CenterAMPHAmphastar Pharmaceuticals, Inc.Sale$239K 10,000 shares at $23.94 5.6% of stakeTraded Sep 16 Filed Sep 17
-
Christopher K Cox Chief Product OfficerMETAMeta Platforms, Inc., Class APlanned sale$13.5M 20,000 shares at $675.23 8.2% of stakeTraded Sep 15 Filed Sep 17
-
Kurt James Wolf CEOPBIPitney Bowes Inc.Planned sale$3.5M 199,258 shares at $17.34 66% of stakeTraded Sep 15–17 Filed Sep 17
-
Robert H Schingler FounderPLPlanet Labs PBCPlanned sale$886K 52,240 shares at $16.96 24% of stakeTraded Sep 17 Filed Sep 17
-
Brian J Brille See RemarksCAICaris Life Sciences, Inc.Sale$12.1M 400,000 shares at $30.33 64% of stakeTraded Sep 17 Filed Sep 17
-
Arora Ashish CEOCRCTCricut, Inc.Planned sale$1M 180,000 shares at $5.62 3.2% of stakeTraded Sep 15–17 Filed Sep 17
-
Steve Ladd Huffman CEORDDTReddit, Inc.Planned sale$2.8M 17,308 shares at $160.11 4.9% of stakeTraded Sep 15 Filed Sep 17
-
Joshua Jergensen COOPACSPACS Group, Inc.Planned sale$1.7M 40,000 shares at $43.13 1.6% of stakeTraded Sep 16 Filed Sep 17
-
Donald McClymont CEOINDIindie Semiconductor, Inc.Planned sale$155K 50,000 shares at $3.11 9.4% of stakeTraded Sep 15 Filed Sep 17
-
Todd S Nelson CEOPRDOPerdoceo Education CorporationPlanned sale$1.5M 46,199 shares at $32.89 13% of stakeTraded Sep 15 Filed Sep 17
-
Huiwen Yao Chief Technology OfficerASTSAST SpaceMobile, Inc.Planned sale$2.4M 40,000 shares at $58.93 54% of stakeTraded Sep 16 Filed Sep 17
-
Shanti B. Gupta COOASTSAST SpaceMobile, Inc.Sale$707K 12,000 shares at $58.89 2.5% of stakeTraded Sep 16 Filed Sep 17
-
Rhonda Farnum SVP, Comm & Medical AffairsTBPHTheravance Biopharma, Inc.Planned sale$227K 13,314 shares at $17.03 5.9% of stakeTraded Sep 15 Filed Sep 17
-
Paul Cunningham Sr. Vice PresidentCDNSCadence Design Systems, Inc.Planned sale$554K 2,000 shares at $277.12 1.6% of stakeTraded Sep 15 Filed Sep 17
-
Jayme Mendal CEOEVEREverQuote, Inc.Planned sale$509K 20,981 shares at $24.27 3.4% of stakeTraded Sep 15 Filed Sep 17
-
John Kenneweg SVP, Sales & Product MarketingMASS908 Devices Inc.Planned sale$280K 27,656 shares at $10.13 32% of stakeTraded Sep 15–17 Filed Sep 17
-
Todd P. Kelsey CEOPLXSPlexus Corp.Planned sale$364K 1,500 shares at $242.41 2.3% of stakeTraded Sep 16 Filed Sep 17
-
Darya Chudova Chief Technology OfficerGHGuardant Health, Inc.Sale$1.4M 7,738 shares at $178.00 9.9% of stakeTraded Sep 15 Filed Sep 17
-
Brian Mandell Executive Vice PresidentPSXPhillips 66Sale$6.2M 23,400 shares at $265.06 28% of stakeTraded Sep 16 Filed Sep 17
-
Santiago Campos Chevallier MD Betterware MexicoBWMXBetterware de Mexico, S.A.P.I. de C.V.Buy$247K 15,000 shares at $16.46 +46% to stakeTraded Sep 16 Filed Sep 17
-
Luis Campos ChairBWMXBetterware de Mexico, S.A.P.I. de C.V.Buy$1.3M 80,000 shares at $16.34 +0.4% to stakeTraded Sep 15–16 Filed Sep 17
-
Andres Campos Chevallier CEOBWMXBetterware de Mexico, S.A.P.I. de C.V.Buy$740K 45,000 shares at $16.44 +90% to stakeTraded Sep 15–16 Filed Sep 17
-
David B Weinstock CFOESNTEssent Group Ltd.Planned sale$377K 5,500 shares at $68.54 16% of stakeTraded Sep 15 Filed Sep 17
-
Richard C Cary Controller, CAOAJGArthur J. Gallagher & Co.Sale$253K 1,000 shares at $252.86 2.1% of stakeTraded Sep 15 Filed Sep 17
-
Shelly Brown EVP, Chief Strategy OfficerMIAXMiami International Holdings, Inc.Planned sale$819K 21,217 shares at $38.61 6.3% of stakeTraded Sep 16 Filed Sep 17
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.8M 9,500 shares at $501.39 2.8% of stakeTraded Sep 16 Filed Sep 17
-
Keith D Larson General Counsel and SecretaryVGVenture Global, Inc.Planned sale$11.5M 789,958 shares at $14.61 100% of stakeTraded Sep 16–17 Filed Sep 17
-
Shiv Verma CFOHOODRobinhood Markets, Inc.Planned sale$1.3M 11,472 shares at $110.42 17% of stakeTraded Sep 15 Filed Sep 17
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$15.4M 24,741 shares at $621.00 4.6% of stakeTraded Sep 15–16 Filed Sep 17
-
Amitabh Misra Chief Technology OfficerCXMSprinklr, Inc.Planned sale$229K 40,000 shares at $5.73 4.7% of stakeTraded Sep 15 Filed Sep 17
-
David C Bernstein Chief Accounting OfficerABNBAirbnb Inc.Planned sale$252K 1,489 shares at $168.93 3.1% of stakeTraded Sep 15 Filed Sep 17
-
Marshall Fordyce CEOVERAVera Therapeutics, Inc.Planned sale$685K 18,500 shares at $37.00 7.3% of stakeTraded Sep 15 Filed Sep 17
-
Michael S. Turner Chief Legal OfficerHAWKHawkEye 360, Inc.Planned sale$296K 18,256 shares at $16.24 9.2% of stakeTraded Sep 16 Filed Sep 17
-
Timothy Holme Chief Technology OfficerQSQuantumScape CorporationPlanned sale$611K 120,000 shares at $5.09Traded Sep 15 Filed Sep 17
-
Gary B Smith CEOCIENCiena CorporationPlanned sale$975K 2,952 shares at $330.18 1.2% of stakeTraded Sep 15 Filed Sep 17
-
David M Rothenstein EVP & Chief Strategy OfficerCIENCiena CorporationPlanned sale$826K 2,500 shares at $330.48 1.4% of stakeTraded Sep 15 Filed Sep 17
-
Forrest Eugene Norrod EVP & GM DsgAMDAdvanced Micro Devices, Inc.Planned sale$8.7M 17,261 shares at $503.05 4.5% of stakeTraded Sep 15 Filed Sep 17
-
Brodie Gage EVP & Chief Product &CIENCiena CorporationPlanned sale$390K 1,200 shares at $324.86 3.1% of stakeTraded Sep 15 Filed Sep 17
-
Dino DiPerna EVP & Chief R&D OfficerCIENCiena CorporationPlanned sale$168K 498 shares at $337.43 1.3% of stakeTraded Sep 15–16 Filed Sep 17
-
Harry Skip Kiil EVP & President CardiovascularMDTMedtronic plcSale$139K 1,483 shares at $93.65 3.4% of stakeTraded Sep 16 Filed Sep 17
-
Robert Boyle SVP, GC and SecretaryPHINPHINIA Inc.Sale$466K 7,500 shares at $62.12 23% of stakeTraded Sep 15 Filed Sep 17
-
Soleil Boughton Chief Legal OfficerHIMSHims & Hers Health, Inc.Planned sale$174K 6,236 shares at $27.86 2% of stakeTraded Sep 16 Filed Sep 17
-
Michael Chi COOHIMSHims & Hers Health, Inc.Planned sale$398K 14,027 shares at $28.39 3% of stakeTraded Sep 15 Filed Sep 17
-
Mohamed Elshenawy CTOHIMSHims & Hers Health, Inc.Planned sale$226K 7,954 shares at $28.39 4.1% of stakeTraded Sep 15 Filed Sep 17
-
Jeffrey S Lorberbaum CEOMHKMohawk Industries, Inc.Sale$2.9M 22,875 shares at $128.59 5.7% of stakeTraded Sep 15–16 Filed Sep 17
-
Mark Hopman Chief Commercial OfficerBBNXBeta Bionics, Inc.Planned sale$620K 30,779 shares at $20.13 35% of stakeTraded Sep 16 Filed Sep 17
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.